VRNA Verona Pharma Corp Gross Profit Margin

Corporate emblem and logo of Verona Pharma Corp (VRNA)

How is the profitability of Verona Pharma plc (VRNA) from Ohtuvayre sales generated? The gross margin percentage reflects efficiency dynamics, with the current metric level standing at 94.60. The business relies on a combination of unique molecules and proprietary nebulizers for precise delivery. Following FDA approval, the drug began commercial growth, offering COPD patients a fundamentally new way to improve breathing.

VRNA - Verona Pharma plc Gross Margin over the range 07/04/2022 - 10/18/2025

Analytical breakdowns and data insights for company Verona Pharma Corp (VRNA)

Fundamental valuation:Verona Pharma (VRNA)
Manufactured products of Verona Pharma PLC

Professional selection of blue-chip assets requires a rigorous analysis of operating expense efficiency. Gross margin measures the profit share after deducting direct production costs, determining a business's ability to generate cash flow. For Verona Pharma plc (VRNA), reliance on outsourced manufacturing directly impacts this metric, which currently stands at 94.60. The trend of gross income as a percentage of revenue allows for an assessment of the company's resilience to market competition.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Return on Sales MENS (Jyong Biotech Corp)|Gross Profitability Ligand (LGND)|Gross Margin amneal.com (AMRX)|Gross Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Gross Profit Margin|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin